AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...
Clinical trial sponsors expanding studies across Europe often face complex regulatory pathways for sample testing, ...
Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Industry groups have asked the US Food and Drug Administration (FDA) to provide more clarity about its regulatory approach to ...
The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...
AMT-260 was generally well-tolerated with no serious adverse events observed to date, with early biological signals of potential therapeutic ...
Scott Piergrossi, president of creative for the healthcare industry naming giant Brand Institute, estimated that acronyms only make up about one-third of the trial names the institute helps create.
18d
GOP bill would use opioid funds to jump-start clinical trials on psychedelic-based trauma treatment
Can a psychedelic drug with heavy side-effects and anecdotal evidence as a treatment for addiction become a wonder drug for veterans facing opioid substance abuse and post-traumatic stress disorders?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results